AcelRx Pharmaceuticals Inc

ACRX 
(NASDAQ) 
 
$ 2.950 <%= Resources.Global.txtDown %>
Updated 18/05/2018
Change % -1.67% Stock price decreasing
Change -0.05 Stock price decreasing
Volume 99,056
High $ 3.000
Low $ 2.900
Open $ 3.000
ISIN
Prev close $ 3.000
# of shares 51.32M
Market cap 151.40M USD
Intraday

Market closed
AcelRx Pharmaceuticals Inc
Market is open (until 21:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  2.95 15.7% Stock price increasing 25.5% Stock price increasing 57.3% Stock price increasing 42.2% Stock price increasing 11.3% Stock price increasing
Powered by TradingView

Company profile

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of the therapies for the treatment of moderate to severe acute pain. Its main product candidates include Dsuvia, Zalviso, and ARX-04. The company generates the revenue from collaboration agreements which includes license fees, cost reimbursement, development and manufacturing services, payments and royalties.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 May 2018 13:34:15
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB4 - 2018-05-21 14:34:15 - 2018-05-21 13:34:15 - 1000 - Website: OKAY